Undiagnosed, untreated blood disorders in women and young girls have medical consequences and unique issues at every life stage, creating the need for a foundation dedicated to education and awareness.
We work to achieve this goal by raising awareness and educating the key healthcare providers for each particular life stage and translating and disseminating provider information and research.
Dr. Leslie Appiah of the University of Colorado will be presenting at NASPAG's upcoming Fertility Preservation: Optimizing Outcomes webinar on January 13 from 8-9 pm ET.
Our congratulations to Dr. Roshni Kulkarni, FWGBD Co-Founder and Board Member, for her selection as the 2022 Coalition for Hemophilia B's Eternal Spirit Award.
MAC Member Dr. Michael Paidas has co-developed a novel therapeutic that acts as a "net" to prevent COVID-19 from entering cells.
Dr. Andrew is researching clinical trial design for postpartum women with risk of venous thromboembolism (VTE).
NASPAG has created a set of talking points to help health care providers answer questions from parents and adolescents about the safety and efficacy of the Pfizer-BioNtech vaccine.
The CDC has recently released updated statistics about hemophilia characteristics among women and girls receiving care at specialized Hemophilia Treatment Centers (HTCs) in the United States.
Join the World Federation of Hemophilia on Thursday, December 16, 2021 from 8:00-10:00 am EST for a webinar on practical information on bleeding disorders.
The Stop the Clot, Spread the Word® campaign, a joint effort of the National Blood Clot Alliance and the Centers for Disease Control and Prevention, is offering a new toolkit for pregnant women and new moms to highlight the risks of blood clots.
The THSNA 2022 Summit will now be held from August 25-27, 2022, in Chicago, IL.
Ming Y. Lim, MBBChir, MSCR received our Research Fellowship Award for a study on von Willebrand disease.
